Uncovering the components of the Francisella tularensis virulence stealth strategy

Frontiers in Cellular and Infection Microbiology

Volumn 5, Issue MAR, 2014, Pages

  Jones, Bradley D ^a,b   Faron, Matthew ^a   Rasmussen, Jed A ^a   Fletcher, Joshua R ^a  

^a UNIVERSITY OF IOWA   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Capsule mutant; FPI virulence genes; Francisella tularensis; Phagosome escape; Stealth strategy; Unique LPS; Virulent schu S4

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD63 ANTIGEN; EARLY ENDOSOME ANTIGEN 1; GAMMA GLUTAMYLTRANSFERASE; GLYCOPROTEIN; INTERLEUKIN 10; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; PROSTAGLANDIN E2; RAB PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR; LIPOPOLYSACCHARIDE; O ANTIGEN; PLASMIN;

ADAPTIVE IMMUNITY; BACTERIAL VIRULENCE; CD4+ T LYMPHOCYTE; CELL INTERACTION; FRANCISELLA NOVICIDA; FRANCISELLA TULARENSIS; GENE EXPRESSION; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; MELIOIDOSIS; MUTAGENESIS; NEUTROPHIL; NONHUMAN; OPSONIZATION; PATHOGENESIS; PHAGOCYTE; PHAGOSOME; PHENOTYPE; PURINE SYNTHESIS; REVIEW; TULAREMIA; WESTERN BLOTTING; ANIMAL; CAPSULE MUTANT; FPI VIRULENCE GENES; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MUTATION; PATHOGENICITY; PATHOLOGY; PHAGOSOME ESCAPE; STEALTH STRATEGY; UNIQUE LPS; VIRULENCE; VIRULENT SCHU S4; ARTICLE; BACTERIAL CAPSULE; MUTANT;

CAPSULE MUTANT; FPI VIRULENCE GENES; FRANCISELLA TULARENSIS; PHAGOSOME ESCAPE; STEALTH STRATEGY; UNIQUE LPS; VIRULENT SCHU S4;

ANIMALS; FRANCISELLA TULARENSIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; MUTATION; TULAREMIA; VIRULENCE; VIRULENCE FACTORS;

EID: 84898727487     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2014.00032     Document Type: Review

References (107)

1. Alkhuder, K., Meibom, K. L., Dubail, I., Dupuis, M., and Charbit, A. (2009). Glutathione provides a source of cysteine essential for intracellular multiplication of Francisella tularensis. PLoS Pathog. 5:e1000284. doi: 10.1371/journal.ppat.1000284
2. Anthony, L. D., Burke, R. D., and Nano, F. E.(1991). Growth of Francisella spp. in rodent macrophages. Infect. immun. 59, 3291-3296.
3. Apicella, M. A., Post, D. M., Fowler, A. C., Jones, B. D., Rasmussen, J. A., Hunt, J. R., et al. (2010). Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis. PLoS ONE 5:e11060. doi: 10.1371/journal.pone.0011060
4. Asakrah, S., Nieves, W., Mahdi, Z., Agard, M., Zea, A. H., Roy, C. J., et al. (2013). Post-exposure therapeutic efficacy of COX-2 inhibition against Burkholderia pseudomallei. PLoS Negl. Trop. Dis. 7:e2212. doi: 10.1371/journal.pntd.0002212
5. Balagopal, A., MacFarlane, A. S., Mohapatra, N., Soni, S., Gunn, J. S., and Schlesinger, L. S. (2006). Characterization of the receptor-ligand pathways important for entry and survival of Francisella tularensis in human macrophages. Infect. Immun. 74, 5114-5125. doi: 10.1128/IAI.00795-06
6. Balonova, L., Hernychova, L., Mann, B. F., Link, M., Bilkova, Z., Novotny, M. V., et al. (2010). Multimethodological approach to identification of glycoproteins from the proteome of Francisella tularensis, an intracellular microorganism. J. Proteome Res. 9, 1995-2005. doi: 10.1021/pr9011602
7. Balonova, L., Mann, B. F., Cerveny, L., Alley, W. R. Jr. Chovancova, E., Forslund, A. L., et al. (2012). Characterization of protein glycosylation in Francisella tularensis subsp. holarctica: identification of a novel glycosylated lipoprotein required for virulence. Mol. Cell. Proteomics 11:M111.015016. doi: 10.1074/mcp.M111.015016
8. Bandara, A. B., Champion, A. E., Wang, X., Berg, G., Apicella, M. A., McLendon, M., et al. (2011). Isolation and mutagenesis of a capsule-like complex (CLC) from Francisella tularensis, and contribution of the CLC to F. tularensis virulence in mice. PLoS ONE 6:e19003. doi: 10.1371/journal.pone.0019003
9. Barak, J. D., Jahn, C. E., Gibson, D. L., and Charkowski, A. O. (2007). The role of cellulose and O-antigen capsule in the colonization of plants by Salmonella enterica. Mol. Plant Microbe Interact. 20, 1083-1091. doi: 10.1094/MPMI-20-9-1083
10. Barker, J. R., and Klose, K. E. (2007). Molecular and genetic basis of pathogenesis in Francisella tularensis. Ann. N.Y. Acad. Sci. 1105, 138-159. doi: 10.1196/annals.1409.010
11. Ben Nasr, A., Haithcoat, J., Masterson, J. E., Gunn, J. S., Eaves-Pyles, T., and Klimpel, G. R. (2006). Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria. J. Leukoc. Biol. 80, 774-786. doi: 10.1189/jlb.1205755
12. Berri, F., Rimmelzwaan, G. F., Hanss, M., Albina, E., Foucault-Grunenwald, M. L., Le, V. B., et al. (2013). Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. PLoS Pathog. 9:e1003229. doi: 10.1371/journal.ppat.1003229
13. Beutler, B., and Poltorak, A. (2000). Positional cloning of Lps, and the general role of toll-like receptors in the innate immune response. Eur. Cytokine Netw. 11, 143-152.
14. Bonquist, L., Lindgren, H., Golovliov, I., Guina, T., and Sjostedt, A. (2008). MglA and Igl proteins contribute to the modulation of Francisella tularensis live vaccine strain-containing phagosomes in murine macrophages. Infect. Immun. 76, 3502-3510. doi: 10.1128/IAI.00226-08
15. Bosio, C. M. (2011). The subversion of the immune system by Francisella tularensis. Front. Microbiol. 2:9. doi: 10.3389/fmicb.2011.00009
16. Brotcke, A., and Monack, D. M. (2008). Identification of fevR, a novel regulator of virulence gene expression in Francisella novicida. Infect. Immun. 76, 3473-3480. doi: 10.1128/IAI.00430-08
17. Brotcke, A., Weiss, D. S., Kim, C. C., Chain, P., Malfatti, S., Garcia, E., et al. (2006). Identification of MglA-regulated genes reveals novel virulence factors in Francisella tularensis. Infect. Immun. 74, 6642-6655. doi: 10.1128/IAI.01250-06
18. Buchan, B. W. (2009). Examining the Regulation of Virulence Factors in Francisella tularensis. Ph.D., The University of Iowa.
19. Buchan, B. W., McCaffrey, R. L., Lindemann, S. R., Allen, L. A., and Jones, B. D. (2009). Identification of migR, a regulatory element of the Francisella tularensis live vaccine strain iglABCD virulence operon required for normal replication and trafficking in macrophages. Infect. Immun. 77, 2517-2529. doi: 10.1128/IAI.00229-09
20. Celli, J., and Zahrt, T. C. (2013). Mechanisms of Francisella tularensis intracellular pathogenesis. Cold Spring Harb. Perspect. Med. 3:a010314. doi: 10.1101/cshperspect.a010314
21. Charity, J. C., Blalock, L. T., Costante-Hamm, M. M., Kasper, D. L., and Dove, S. L. (2009). Small molecule control of virulence gene expression in Francisella tularensis. PLoS Pathog. 5:e1000641. doi: 10.1371/journal.ppat.1000641
22. Checroun, C., Wehrly, T. D., Fischer, E. R., Hayes, S. F., and Celli, J. (2006). Autophagy-mediated reentry of Francisella tularensis into the endocytic compartment after cytoplasmic replication. Proc. Natl. Acad. Sci. U.S.A. 103, 14578-14583. doi: 10.1073/pnas.0601838103
23. Chen, Y., Bystricky, P., Adeyeye, J., Panigrahi, P., Ali, A., Johnson, J. A., et al. (2007). The capsule polysaccharide structure and biogenesis for non-O1 Vibrio cholerae NRT36S: genes are embedded in the LPS region. BMC Microbiol. 7:20. doi: 10.1186/1471-2180-7-20
24. Chong, A., Wehrly, T. D., Child, R., Hansen, B., Hwang, S., Virgin, H. W., et al. (2012). Cytosolic clearance of replication-deficient mutants reveals Francisella tularensis interactions with the autophagic pathway. Autophagy 8, 1342-1356. doi: 10.4161/auto.20808
25. Chong, A., Wehrly, T. D., Nair, V., Fischer, E. R., Barker, J. R., Klose, K. E., et al. (2008). The early phagosomal stage of Francisella tularensis determines optimal phagosomal escape and Francisella pathogenicity island protein expression. Infect. Immun. 76, 5488-5499. doi: 10.1128/IAI.00682-08
26. Clay, C. D., Soni, S., Gunn, J. S., and Schlesinger, L. S. (2008). Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen. J. Immunol. 181, 5568-5578.
27. Clemens, D. L., Lee, B. Y., and Horwitz, M. A. (2004). Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages. Infect. Immun. 72, 3204-3217. doi: 10.1128/IAI.72.6.3204-3217.2004
28. Clemens, D. L., Lee, B. Y., and Horwitz, M. A. (2009). Francisella tularensis phagosomal escape does not require acidification of the phagosome. Infect. Immun. 77, 1757-1773. doi: 10.1128/IAI.01485-08
29. Cole, L. E., Yang, Y., Elkins, K. L., Fernandez, E. T., Qureshi, N., Shlomchik, M. J., et al. (2009). Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge. Proc. Natl. Acad. Sci. U.S.A. 106, 4343-4348. doi: 10.1073/pnas.0813411106
30. Conlan, J. W. (2011). Tularemia vaccines: recent developments and remaining hurdles. Future Microbiol. 6, 391-405. doi: 10.2217/fmb.11.22
31. Conlan, J. W., and North, R. J. (1992). Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes. Infect. Immun. 60, 5164-5171.
32. Conlan, J. W., Shen, H., Golovliov, I., Zingmark, C., Oyston, P. C., Chen, W., et al. (2010). Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization. Vaccine 28, 1824-1831. doi: 10.1016/j.vaccine.2009.12.001
33. Cowley, S. C., and Elkins, K. L. (2011). Immunity to Francisella. Front. Microbiol. 2:26. doi: 10.3389/fmicb.2011.00026
34. Crane, D. D., Griffin, A. J., Wehrly, T. D., and Bosio, C. M. (2013). B1a cells enhance susceptibility to infection with virulent Francisella tularensis via modulation of NK/NKT cell responses. J. Immunol. 190, 2756-2766. doi: 10.4049/jimmunol.1202697
35. Crane, D. D., Scott, D. P., and Bosio, C. M. (2012). Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia. PLoS ONE 7:e33349. doi: 10.1371/journal.pone.0033349
36. Crane, D. D., Warner, S. L., and Bosio, C. M. (2009). A novel role for plasmin-mediated degradation of opsonizing antibody in the evasion of host immunity by virulent, but not attenuated, Francisella tularensis. J. Immunol. 183, 4593-4600. doi: 10.4049/jimmunol.0901655
37. Daly, J. M., Jannot, C. B., Beerli, R. R., Graus-Porta, D., Maurer, F. G., and Hynes, N. E. (1997). Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells. Cancer Res. 57, 3804-3811.
38. de Bruin, O. M., Ludu, J. S., and Nano, F. E. (2007). The Francisella pathogenicity island protein IglA localizes to the bacterial cytoplasm and is needed for intracellular growth. BMC Microbiol. 7:1. doi: 10.1186/1471-2180-7-1
39. Dennis, D. T., Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., et al. (2001). Tularemia as a biological weapon: medical and public health management. JAMA 285, 2763-2773. doi: 10.1001/jama.285.21.2763
40. Edwards, J. A., Rockx-Brouwer, D., Nair, V., and Celli, J. (2010). Restricted cytosolic growth of Francisella tularensis subsp. tularensis by IFN-gamma activation of macrophages. Microbiology 156, 327-339. doi: 10.1099/mic.0.031716-0
41. Egge-Jacobsen, W., Salomonsson, E. N., Aas, F. E., Forslund, A. L., Winther-Larsen, H. C., Maier, J., et al. (2011). O-linked glycosylation of the PilA pilin protein of Francisella tularensis: identification of the endogenous protein-targeting oligosaccharyltransferase and characterization of the native oligosaccharide. J. Bacteriol. 193, 5487-5497. doi: 10.1128/JB.00383-11
42. Elkins, K. L., Cowley, S. C., and Bosio, C. M. (2003). Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain. Microbes Infect. 5, 135-142. doi: 10.1016/S1286-4579(02)00084-9
43. Eneslatt, K., Normark, M., Bjork, R., Rietz, C., Zingmark, C., Wolfraim, L. A., et al. (2012). Signatures of T cells as correlates of immunity to Francisella tularensis. PLoS ONE 7:e32367. doi: 10.1371/journal.pone.0032367
44. Faron, M., Fletcher, J. R., Rasmussen, J. A., Long, M. E., Allen, L. A., and Jones, B. D. (2013). The Francisella tularensis migR, trmE, and cphA genes contribute to F. tularensis pathogenicity island gene regulation and intracellular growth by modulation of the stress alarmone ppGpp. >Infect. Immun. 81, 2800-2811. doi: 10.1128/IAI.00073-13
45. Forestal, C. A., Benach, J. L., Carbonara, C., Italo, J. K., Lisinski, T. J., and Furie, M. B. (2003). Francisella tularensis selectively induces proinflammatory changes in endothelial cells. J. Immunol. 171, 2563-2570.
46. Foshay, L. (1946). A comparative study of the treatment of tularemia with immune serum, hyperimmune serum and streptomycin. Am. J. Med. 1, 180-188. doi: 10.1016/0002-9343(46)90036-8
47. Fuller, J. R., Craven, R. R., Hall, J. D., Kijek, T. M., Taft-Benz, S., and Kawula, T. H. (2008). RipA, a cytoplasmic membrane protein conserved among Francisella species, is required for intracellular survival. Infect. Immun. 76, 4934-4943. doi: 10.1128/IAI.00475-08
48. Geier, H., and Celli, J. (2011). Phagocytic receptors dictate phagosomal escape and intracellular proliferation of Francisella tularensis. Infect. Immun. 79, 2204-2214. doi: 10.1128/IAI.01382-10
49. Gesbert, G., Ramond, E., Rigard, M., Frapy, E., Dupuis, M., Dubail, I., et al. (2013). Asparagine assimilation is critical for intracellular replication and dissemination of Francisella. Cell. Microbiol. 15, 1-16. doi: 10.1111/cmi.12227
50. Golovliov, I., Baranov, V., Krocova, Z., Kovarova, H., and Sjostedt, A. (2003). An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells. Infect. Immun. 71, 5940-5950. doi: 10.1128/IAI.71.10.5940-5950.2003
51. Gunn, J. S., and Ernst, R. K. (2007). The structure and function of Francisella lipopolysaccharide. Ann. N.Y. Acad. Sci. 1105, 202-218. doi: 10.1196/annals.1409.006
52. Hajjar, A. M., Harvey, M. D., Shaffer, S. A., Goodlett, D. R., Sjostedt, A., Edebro, H., et al. (2006). Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors. Infect. Immun. 74, 6730-6738. doi: 10.1128/IAI.00934-06
53. Hood, A. M. (1977). Virulence factors of Francisella tularensis. J. Hyg. (Lond.) 79, 47-60. doi: 10.1017/S0022172400052840
54. Horzempa, J., O'Dee, D. M., Shanks, R. M., and Nau, G. J. (2010). Francisella tularensis DeltapyrF mutants show that replication in nonmacrophages is sufficient for pathogenesis in vivo. Infect. Immun. 78, 2607-2619. doi: 10.1128/IAI.00134-10
55. Hunt, D., Wilson, J. E., Weih, K. A., Ishido, S., Harton, J. A., Roche, P. A., et al. (2012). Francisella tularensis elicits IL-10 via a PGE(2)-inducible factor, to drive macrophage MARCH1 expression and class II down-regulation. PLoS ONE 7:e37330. doi: 10.1371/journal.pone.0037330
56. Jayaratne, P., Keenleyside, W. J., MacLachlan, P. R., Dodgson, C., and Whitfield, C. (1993). Characterization of rcsB and rcsC from Escherichia coli O9:K30:H12 and examination of the role of the rcs regulatory system in expression of group I capsular polysaccharides. J. Bacteriol. 175, 5384-5394.
57. Jones, C. L., Napier, B. A., Sampson, T. R., Llewellyn, A. C., Schroeder, M. R., and Weiss, D. S. (2012). Subversion of host recognition and defense systems by Francisella spp. Microbiol. Mol. Biol. Rev. 76, 383-404. doi: 10.1128/MMBR.05027-11
58. Kanistanon, D., Powell, D. A., Hajjar, A. M., Pelletier, M. R., Cohen, I. E., Way, S. S., et al. (2012). Role of Francisella lipid A phosphate modification in virulence and long-term protective immune responses. Infect. Immun. 80, 943-951. doi: 10.1128/IAI.06109-11
59. Kirimanjeswara, G. S., Olmos, S., Bakshi, C. S., and Metzger, D. W. (2008). Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis. Immunol. Rev. 225, 244-255. doi: 10.1111/j.1600-065X.2008.00689.x
60. Kurtz, S. L., Foreman, O., Bosio, C. M., Anver, M. R., and Elkins, K. L. (2013). Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection. Infect. Immun. 81, 585-597. doi: 10.1128/IAI.01249-12
61. Lai, X. H., Golovliov, I., and Sjostedt, A. (2001). Francisella tularensis induces cytopathogenicity and apoptosis in murine macrophages via a mechanism that requires intracellular bacterial multiplication. Infect. Immun. 69, 4691-4694. doi: 10.1128/IAI.69.7.4691-4694.2001
62. Lai, X. H., Golovliov, I., and Sjostedt, A. (2004). Expression of IglC is necessary for intracellular growth and induction of apoptosis in murine macrophages by Francisella tularensis. Microb. Pathog. 37, 225-230. doi: 10.1016/j.micpath.2004.07.002
63. Lai, X. H., and Sjostedt, A. (2003). Delineation of the molecular mechanisms of Francisella tularensis-induced apoptosis in murine macrophages. Infect. Immun. 71, 4642-4646. doi: 10.1128/IAI.71.8.4642-4646.2003
64. Lauriano, C. M., Barker, J. R., Yoon, S. S., Nano, F. E., Arulanandam, B. P., Hassett, D. J., et al. (2004). MglA regulates transcription of virulence factors necessary for Francisella tularensis intraamoebae and intramacrophage survival. Proc. Natl. Acad. Sci. U.S.A. 101, 4246-4249. doi: 10.1073/pnas.0307690101
65. Laws, T. R., Clark, G., and D'Elia, R. V. (2013). Differential role for interleukin-6 during Francisella tularensis infection with virulent and vaccine strains. Infect. Immun. 81, 3055-3056. doi: 10.1128/IAI.00234-13
66. Lindemann, S. R., McLendon, M. K., Apicella, M. A., and Jones, B. D. (2007). An in vitro model system used to study adherence and invasion of Francisella tularensis live vaccine strain in nonphagocytic cells. Infect. Immun. 75, 3178-3182. doi: 10.1128/IAI.01811-06
67. Lindemann, S. R., Peng, K., Long, M. E., Hunt, J. R., Apicella, M. A., Monack, D. M., et al. (2011). Francisella tularensis Schu S4 O-antigen and capsule biosynthesis gene mutants induce early cell death in human macrophages. Infect. Immun. 79, 581-594. doi: 10.1128/IAI.00863-10
68. Ludu, J. S., de Bruin, O. M., Duplantis, B. N., Schmerk, C. L., Chou, A. Y., Elkins, K. L., et al. (2008). The Francisella pathogenicity island protein PdpD is required for full virulence and associates with homologues of the type VI secretion system. J. Bacteriol. 190, 4584-4595. doi: 10.1128/JB.00198-08
69. Marohn, M. E., Santiago, A. E., Shirey, K. A., Lipsky, M., Vogel, S. N., and Barry, E. M. (2012). Members of the Francisella tularensis phagosomal transporter subfamily of major facilitator superfamily transporters are critical for pathogenesis. Infect. Immun. 80, 2390-2401. doi: 10.1128/IAI.00144-12
70. McCaffrey, R. L., and Allen, L. A. (2006). Francisella tularensis LVS evades killing by human neutrophils via inhibition of the respiratory burst and phagosome escape. J. Leukoc. Biol. 80, 1224-1230. doi: 10.1189/jlb.0406287
71. McLendon, M. K., Apicella, M. A., and Allen, L. A. (2006). Francisella tularensis: taxonomy, genetics, and immunopathogenesis of a potential agent of biowarfare. Annu. Rev. Microbiol. 60, 167-185. doi: 10.1146/annurev.micro.60.080805.142126
72. Metzger, D. W., Salmon, S. L., and Kirimanjeswara, G. (2013). Differing effects of interleukin-10 on cutaneous and pulmonary Francisella tularensis live vaccine strain infection. Infect. Immun. 81, 2022-2027. doi: 10.1128/IAI.00024-13
73. Moreland, J. G., Hook, J. S., Bailey, G., Ulland, T., and Nauseef, W. M. (2009). Francisella tularensis directly interacts with the endothelium and recruits neutrophils with a blunted inflammatory phenotype. Am. J. Physiol. Lung Cell. Mol. Physiol. 296, L1076-L1084. doi: 10.1152/ajplung.90332.2008
74. Nano, F. E., and Schmerk, C. (2007). The Francisella pathogenicity island. Ann. N.Y. Acad. Sci. 1105, 122-137. doi: 10.1196/annals.1409.000
75. Nano, F. E., Zhang, N., Cowley, S. C., Klose, K. E., Cheung, K. K., Roberts, M. J., et al. (2004). A Francisella tularensis pathogenicity island required for intramacrophage growth. J. Bacteriol. 186, 6430-6436. doi: 10.1128/JB.186.19.6430-6436.2004
76. Orskov, I., Orskov, F., Jann, B., and Jann, K. (1977). Serology, chemistry, and genetics of O and K antigens of Escherichia coli. Bacteriol. Rev. 41, 667-710.
77. Pechous, R., Celli, J., Penoske, R., Hayes, S. F., Frank, D. W., and Zahrt, T. C. (2006). Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain. Infect. Immun. 74, 4452-4461. doi: 10.1128/IAI.00666-06
78. Pechous, R. D., McCarthy, T. R., Mohapatra, N. P., Soni, S., Penoske, R. M., Salzman, N. H., et al. (2008). A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge. PLoS ONE 3:e2487. doi: 10.1371/journal.pone.0002487
79. Peleg, A., Shifrin, Y., Ilan, O., Nadler-Yona, C., Nov, S., Koby, S., et al. (2005). Identification of an Escherichia coli operon required for formation of the O-antigen capsule. J. Bacteriol. 187, 5259-5266. doi: 10.1128/JB.187.15.5259-5266.2005
80. Phillips, N. J., Schilling, B., McLendon, M. K., Apicella, M. A., and Gibson, B. W. (2004). Novel modification of lipid A of Francisella tularensis. Infect. Immun. 72, 5340-5348. doi: 10.1128/IAI.72.9.5340-5348.2004
81. Pierini, L. M. (2006). Uptake of serum-opsonized Francisella tularensis by macrophages can be mediated by class A scavenger receptors. Cell. Microbiol. 8, 1361-1370. doi: 10.1111/j.1462-5822.2006.00719.x
82. Poltorak, A., Smirnova, I., He, X., Liu, M. Y., Van Huffel, C., McNally, O., et al. (1998). Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol. Dis. 24, 340-355. doi: 10.1006/bcmd.1998.0201
83. Qin, A., and Mann, B. J. (2006). Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2. BMC Microbiol. 6:69. doi: 10.1186/1471-2180-6-69
84. Raetz, C. R. (1990). Biochemistry of endotoxins. Annu. Rev. Biochem. 59, 129-170. doi: 10.1146/annurev.bi.59.070190.001021
85. Rasmussen, J. A., Lindemann, S. R., Post, D. M. B., Gibson, B. W., Apicella, M. A., Meyerholz, D. K., et al. (2014). Francisella tularensis Schu S4 capsule and O-antigen mutants are attenuated in a mouse model of Tularemia. Infect. Immun. 82. doi: 10.1128/IAI.01640-13. [Epub ahead of print].
86. Ray, H. J., Cong, Y., Murthy, A. K., Selby, D. M., Klose, K. E., Barker, J. R., et al. (2009). Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A. Clin. Vaccine Immunol. 16, 444-452. doi: 10.1128/CVI.00405-08
87. Rockx-Brouwer, D., Chong, A., Wehrly, T. D., Child, R., Crane, D. D., Celli, J., et al. (2012). Low dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination. PLoS ONE 7:e37752. doi: 10.1371/journal.pone.0037752
88. Sandstrom, G. (1994). The tularaemia vaccine. J. Chem. Technol. Biotechnol. 59, 315-320. doi: 10.1002/jctb.280590402
89. Sandstrom, G., Lofgren, S., and Tarnvik, A. (1988). A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect. Immun. 56, 1194-1202.
90. Santic, M., Molmeret, M., Klose, K. E., and Abu Kwaik, Y. (2006). Francisella tularensis travels a novel, twisted road within macrophages. Trends Microbiol. 14, 37-44. doi: 10.1016/j.tim.2005.11.008
91. Schulert, G. S., and Allen, L. A. (2006). Differential infection of mononuclear phagocytes by Francisella tularensis: role of the macrophage mannose receptor. J. Leukoc. Biol. 80, 563-571. doi: 10.1189/jlb.0306219
92. Schulert, G. S., McCaffrey, R. L., Buchan, B. W., Lindemann, S. R., Hollenback, C., Jones, B. D., et al. (2009). Francisella tularensis genes required for inhibition of the neutrophil respiratory burst and intramacrophage growth identified by random transposon mutagenesis of strain LVS. Infect. Immun. 77, 1324-1336. doi: 10.1128/IAI.01318-08
93. Schwartz, J. T., Barker, J. H., Long, M. E., Kaufman, J., McCracken, J., and Allen, L. A. (2012). Natural IgM mediates complement-dependent uptake of Francisella tularensis by human neutrophils via complement receptors 1 and 3 in nonimmune serum. J. Immunol. 189, 3064-3077. doi: 10.4049/jimmunol.1200816
94. Sharma, J., Mares, C. A., Li, Q., Morris, E. G., and Teale, J. M. (2011). Features of sepsis caused by pulmonary infection with Francisella tularensis Type A strain. Microb. Pathog. 51, 39-47. doi: 10.1016/j.micpath.2011.03.007
95. Straskova, A., Pavkova, I., Link, M., Forslund, A. L., Kuoppa, K., Noppa, L., et al. (2009). Proteome analysis of an attenuated Francisella tularensis dsbA mutant: identification of potential DsbA substrate proteins. J. Proteome Res. 8, 5336-5346. doi: 10.1021/pr900570b
96. Tarnvik, A., and Berglund, L. (2003). Tularaemia. Eur. Respir. J. 21, 361-373. doi: 10.1183/09031936.03.00088903
97. Thomas, R. M., Titball, R. W., Oyston, P. C., Griffin, K., Waters, E., Hitchen, P. G., et al. (2007). The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens. Infect. Immun. 75, 371-378. doi: 10.1128/IAI.01241-06
98. Vinogradov, E., Perry, M. B., and Conlan, J. W. (2002). Structural analysis of Francisella tularensis lipopolysaccharide. Eur. J. Biochem. 269, 6112-6118. doi: 10.1046/j.1432-1033.2002.03321.x
99. Wang, Q., Shi, X., Leymarie, N., Madico, G., Sharon, J., Costello, C. E., et al. (2011). A typical preparation of Francisella tularensis O-antigen yields a mixture of three types of saccharides. Biochemistry 50, 10941-10950. doi: 10.1021/bi201450v
100. Wehrly, T. D., Chong, A., Virtaneva, K., Sturdevant, D. E., Child, R., Edwards, J. A., et al. (2009). Intracellular biology and virulence determinants of Francisella tularensis revealed by transcriptional profiling inside macrophages. Cell. Microbiol. 11, 1128-1150. doi: 10.1111/j.1462-5822.2009.01316.x
101. Weiss, D. S., Brotcke, A., Henry, T., Margolis, J. J., Chan, K., and Monack, D. M. (2007). In vivo negative selection screen identifies genes required for Francisella virulence. Proc. Natl. Acad. Sci. U.S.A. 104, 6037-6042. doi: 10.1073/pnas.0609675104
102. Whitfield, C. (2006). Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu. Rev. Biochem. 75, 39-68. doi: 10.1146/annurev.biochem.75.103004.142545
103. Wilson, J. E., Katkere, B., and Drake, J. R. (2009). Francisella tularensis induces ubiquitin-dependent major histocompatibility complex class II degradation in activated macrophages. Infect. Immun. 77, 4953-4965. doi: 10.1128/IAI.00844-09
104. Woolard, M. D., Wilson, J. E., Hensley, L. L., Jania, L. A., Kawula, T. H., Drake, J. R., et al. (2007). Francisella tularensis-infected macrophages release prostaglandin E2 that blocks T cell proliferation and promotes a Th2-like response. J. Immunol. 178, 2065-2074.
105. Zarrella, T. M., Singh, A., Bitsaktsis, C., Rahman, T., Sahay, B., Feustel, P. J., et al. (2011). Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity. PLoS ONE 6:e22335. doi: 10.1371/journal.pone.0022335
106. Zaslona, Z., Serezani, C. H., Okunishi, K., Aronoff, D. M., and Peters-Golden, M. (2012). Prostaglandin E2 restrains macrophage maturation via E prostanoid receptor 2/protein kinase A signaling. Blood 119, 2358-2367. doi: 10.1182/blood-2011-08-374207
107. Zhang, Y. L., Arakawa, E., and Leung, K. Y. (2002). Novel Aeromonas hydrophila PPD134/91 genes involved in O-antigen and capsule biosynthesis. Infect. Immun. 70, 2326-2335. doi: 10.1128/IAI.70.5.2326-2335.2002